An analysis of the global health R&D pipeline shows important progress, but significant gaps in innovation remain. Only four of the 336 new medicines developed between 2000 and 2011 were for the...
(PRWeb December 13, 2012)
Read the full story at http://www.prweb.com/releases/2012/12/prweb10232779.htm